ArticlePharmaceutics2021

Uptake of Trastuzumab Biosimilars for the Treatment of HER2-Positive Breast Cancer: A Real-World Experience from a Cancer Center.

Michela Piezzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.